VHTETF / FundVANGUARD HEALTH CARE INDEX FUND
Verdicts genuinely change. Free email alert the moment VHT's does — no target price to set, unlike a price alert.
Whether this fund clears the published standards, and the filings behind that answer. The screen runs first and nothing on the trading side can override it.
Structure, momentum, positioning and levels. Separate from the Sharia verdict above, which this side never overrides.
VANGUARD HEALTH CARE INDEX FUND ETF · VANGUARD WORLD FUND
423 holdings · as of 2026-08-31 (2.6 months ago)
NON-COMPLIANT 24.71% of portfolio weight is in non-compliant holdings, over the 5% threshold.
423 holdings, 348 matched (97% of weight). Portfolio as of 2026-08-31, filed 2026-10-29. Source: SEC Form N-PORT.
1.57% of this portfolio’s income is non-permissible — weighted across holdings, computed over 84% of portfolio weight (301 of 423 holdings). The common approach purifies that proportion of income received — dividends — not of the position’s value. We report the ratio; what to do with it is a question for your own scholar.
72.6% compliant 0.0% questionable 24.7% non-compliant 2.7% unscreened
All holdings (423) · showing 251–423
| Holding | Status | Weight | Every methodology, and the debt ratio behind it |
|---|---|---|---|
| HROW Harrow Inc | COMPLIANT | 0.02% | AAOIFIpass Usmanifail Dow Jones Islamicpass S&P Shariahpass MSCI Islamicfail MSCI Islamic M-Seriespass FTSE Shariahfail |
| Kodiak Sciences Inc | UNSCREENED | 0.02% | no in-house ratios for this holding |
| STOK Stoke Therapeutics Inc | NON_COMPLIANT | 0.02% | AAOIFI0.1% Usmani0.5% Dow Jones Islamic0.1% S&P Shariah0.2% MSCI Islamic0.5% MSCI Islamic M-Series0.2% FTSE Shariah0.0% |
| AORT Artivion Inc | NON_COMPLIANT | 0.02% | AAOIFI43.3% Usmani39.1% Dow Jones Islamic27.4% S&P Shariah31.3% MSCI Islamic38.7% MSCI Islamic M-Series31.3% FTSE Shariah34.9% |
| PSNL Personalis Inc | NON_COMPLIANT | 0.02% | AAOIFI2.3% Usmani12.4% Dow Jones Islamic4.6% S&P Shariah6.3% MSCI Islamic12.4% MSCI Islamic M-Series6.3% FTSE Shariah0.0% |
| PRCT Procept Biorobotics Corp | COMPLIANT | 0.02% | AAOIFI5.6% Usmani16.3% Dow Jones Islamic3.4% S&P Shariah3.0% MSCI Islamic16.3% MSCI Islamic M-Series3.0% FTSE Shariah10.9% |
| New Issuer: BB Company ID:69588108 | UNSCREENED | 0.02% | no in-house ratios for this holding |
| TDOC Teladoc Health Inc | NON_COMPLIANT | 0.02% | AAOIFIfail Usmanifail Dow Jones Islamicfail S&P Shariahfail MSCI Islamicfail MSCI Islamic M-Seriesfail FTSE Shariahfail |
| IART Integra LifeSciences Holdings Corp | NON_COMPLIANT | 0.02% | AAOIFI80.3% Usmani24.9% Dow Jones Islamic71.7% S&P Shariah54.0% MSCI Islamic24.9% MSCI Islamic M-Series54.0% FTSE Shariah19.9% |
| ZYME Zymeworks Inc | NON_COMPLIANT | 0.02% | AAOIFI19.4% Usmani33.3% Dow Jones Islamic27.4% S&P Shariah32.6% MSCI Islamic33.3% MSCI Islamic M-Series32.6% FTSE Shariah28.8% |
| SGRY Surgery Partners Inc | NON_COMPLIANT | 0.01% | AAOIFI94.3% Usmani56.1% Dow Jones Islamic136.4% S&P Shariah115.6% MSCI Islamic47.0% MSCI Islamic M-Series115.6% FTSE Shariah43.3% |
| ATEC Alphatec Holdings Inc | NON_COMPLIANT | 0.01% | AAOIFI54.2% Usmani74.5% Dow Jones Islamic32.9% S&P Shariah34.8% MSCI Islamic74.5% MSCI Islamic M-Series34.8% FTSE Shariah68.7% |
| TSHA Taysha Gene Therapies Inc | NON_COMPLIANT | 0.01% | AAOIFI3.9% Usmani12.5% Dow Jones Islamic5.1% S&P Shariah6.4% MSCI Islamic12.5% MSCI Islamic M-Series6.4% FTSE Shariah10.9% |
| AVAH Aveanna Healthcare Holdings Inc | NON_COMPLIANT | 0.01% | AAOIFI53.4% Usmani60.6% Dow Jones Islamic84.0% S&P Shariah105.2% MSCI Islamic60.6% MSCI Islamic M-Series105.2% FTSE Shariah58.7% |
| First Tracks Biotherapeutics Inc | UNSCREENED | 0.01% | no in-house ratios for this holding |
| QDEL QuidelOrtho Corp | NON_COMPLIANT | 0.01% | AAOIFI460.2% Usmani53.9% Dow Jones Islamic181.0% S&P Shariah139.5% MSCI Islamic53.9% MSCI Islamic M-Series139.5% FTSE Shariah50.8% |
| PCRX Pacira BioSciences Inc | UNRATED | 0.01% | AAOIFI23.3% Usmani28.3% Dow Jones Islamic32.3% S&P Shariah31.3% MSCI Islamic28.3% MSCI Islamic M-Series31.3% FTSE Shariah24.4% |
| CERT Certara Inc | COMPLIANT | 0.01% | AAOIFI17.3% Usmani21.3% Dow Jones Islamic19.6% S&P Shariah16.5% MSCI Islamic21.3% MSCI Islamic M-Series16.5% FTSE Shariah20.6% |
| KURA Kura Oncology Inc | NON_COMPLIANT | 0.01% | AAOIFI3.8% Usmani4.6% Dow Jones Islamic3.4% S&P Shariah2.6% MSCI Islamic4.6% MSCI Islamic M-Series2.6% FTSE Shariah1.7% |
| AGL agilon health Inc | COMPLIANT | 0.01% | AAOIFI1.7% Usmani2.1% Dow Jones Islamic3.4% S&P Shariah2.2% MSCI Islamic2.1% MSCI Islamic M-Series2.2% FTSE Shariah2.0% |
| ANAB AnaptysBio Inc | NON_COMPLIANT | 0.01% | AAOIFI0.9% Usmani4.1% Dow Jones Islamic1.1% S&P Shariah1.3% MSCI Islamic4.1% MSCI Islamic M-Series1.3% FTSE Shariah0.0% |
| Aerovate Therapeutics Inc | UNSCREENED | 0.01% | no in-house ratios for this holding |
| CRVS Corvus Pharmaceuticals Inc | COMPLIANT | 0.01% | AAOIFI0.1% Usmani0.3% Dow Jones Islamic0.1% S&P Shariah0.1% MSCI Islamic0.3% MSCI Islamic M-Series0.1% FTSE Shariah0.0% |
| CSTL Castle Biosciences Inc | COMPLIANT | 0.01% | AAOIFI3.6% Usmani6.3% Dow Jones Islamic4.6% S&P Shariah4.9% MSCI Islamic6.3% MSCI Islamic M-Series4.9% FTSE Shariah1.7% |
| ARDX Ardelyx Inc | NON_COMPLIANT | 0.01% | AAOIFI33.0% Usmani43.6% Dow Jones Islamic20.3% S&P Shariah18.8% MSCI Islamic43.6% MSCI Islamic M-Series18.8% FTSE Shariah43.0% |
| N/A | UNSCREENED | 0.01% | no in-house ratios for this holding |
| Inhibrx Biosciences Inc | UNSCREENED | 0.01% | no in-house ratios for this holding |
| ZBIO Zenas Biopharma Inc | NON_COMPLIANT | 0.01% | AAOIFIfail Usmanifail Dow Jones Islamicfail S&P Shariah— MSCI Islamicfail MSCI Islamic M-Series— FTSE Shariahfail |
| PLSE Pulse Biosciences Inc | NON_COMPLIANT | 0.01% | AAOIFI0.2% Usmani3.2% Dow Jones Islamic0.4% S&P Shariah0.5% MSCI Islamic3.2% MSCI Islamic M-Series0.5% FTSE Shariah0.0% |
| CGEM Cullinan Therapeutics Inc | NON_COMPLIANT | 0.01% | AAOIFIfail Usmanifail Dow Jones Islamicfail S&P Shariah— MSCI Islamicfail MSCI Islamic M-Seriesfail FTSE Shariahfail |
| RIGL Rigel Pharmaceuticals Inc | COMPLIANT | 0.01% | AAOIFIpass Usmanipass Dow Jones Islamicpass S&P Shariahpass MSCI Islamicpass MSCI Islamic M-Seriespass FTSE Shariahpass |
| MRVI Maravai LifeSciences Holdings Inc | NON_COMPLIANT | 0.01% | AAOIFI10.4% Usmani37.6% Dow Jones Islamic18.2% S&P Shariah14.2% MSCI Islamic32.8% MSCI Islamic M-Series14.2% FTSE Shariah24.5% |
| SIBN SI-BONE Inc | COMPLIANT | 0.01% | AAOIFI4.1% Usmani16.7% Dow Jones Islamic5.9% S&P Shariah6.1% MSCI Islamic16.7% MSCI Islamic M-Series6.1% FTSE Shariah13.9% |
| COLL Collegium Pharmaceutical Inc | NON_COMPLIANT | 0.01% | AAOIFI30.8% Usmani11.7% Dow Jones Islamic22.9% S&P Shariah22.6% MSCI Islamic11.7% MSCI Islamic M-Series22.6% FTSE Shariah11.4% |
| VREX Varex Imaging Corp | NON_COMPLIANT | 0.01% | AAOIFI79.3% Usmani34.5% Dow Jones Islamic76.5% S&P Shariah67.0% MSCI Islamic34.0% MSCI Islamic M-Series67.0% FTSE Shariah31.6% |
| PAHC Phibro Animal Health Corp | NON_COMPLIANT | 0.01% | AAOIFI46.9% Usmani43.9% Dow Jones Islamic48.5% S&P Shariah59.2% MSCI Islamic43.9% MSCI Islamic M-Series59.2% FTSE Shariah40.3% |
| MGTX MeiraGTx Holdings plc | COMPLIANT | 0.01% | AAOIFI1.4% Usmani2.9% Dow Jones Islamic1.6% S&P Shariah2.0% MSCI Islamic2.9% MSCI Islamic M-Series2.0% FTSE Shariah0.0% |
| Replimune Group Inc | UNSCREENED | 0.01% | no in-house ratios for this holding |
| CYRX CryoPort Inc | NON_COMPLIANT | 0.01% | AAOIFI22.8% Usmani30.7% Dow Jones Islamic44.6% S&P Shariah42.4% MSCI Islamic30.5% MSCI Islamic M-Series42.4% FTSE Shariah24.8% |
| JANX Janux Therapeutics Inc | NON_COMPLIANT | 0.01% | AAOIFI3.1% Usmani2.1% Dow Jones Islamic1.5% S&P Shariah1.3% MSCI Islamic2.1% MSCI Islamic M-Series1.3% FTSE Shariah0.0% |
| AVBP ArriVent Biopharma Inc | NON_COMPLIANT | 0.01% | AAOIFI0.0% Usmani0.1% Dow Jones Islamic0.0% S&P Shariah0.0% MSCI Islamic0.1% MSCI Islamic M-Series0.0% FTSE Shariah0.0% |
| AMPH Amphastar Pharmaceuticals Inc | NON_COMPLIANT | 0.01% | AAOIFI55.2% Usmani40.4% Dow Jones Islamic57.2% S&P Shariah43.9% MSCI Islamic40.4% MSCI Islamic M-Series43.9% FTSE Shariah35.8% |
| ABUS Arbutus Biopharma Corp | NON_COMPLIANT | 0.01% | AAOIFI0.1% Usmani0.1% Dow Jones Islamic0.0% S&P Shariah0.0% MSCI Islamic0.1% MSCI Islamic M-Series0.0% FTSE Shariah0.0% |
| IRMD iRadimed Corp | COMPLIANT | 0.01% | AAOIFI0.0% Usmani0.0% Dow Jones Islamic0.0% S&P Shariah0.0% MSCI Islamic0.0% MSCI Islamic M-Series0.0% FTSE Shariah0.0% |
| GERN Geron Corp | NON_COMPLIANT | 0.01% | AAOIFI20.0% Usmani23.0% Dow Jones Islamic11.6% S&P Shariah8.9% MSCI Islamic23.0% MSCI Islamic M-Series8.9% FTSE Shariah22.8% |
| BCAX Bicara Therapeutics Inc | NON_COMPLIANT | 0.01% | AAOIFI0.1% Usmani0.2% Dow Jones Islamic0.1% S&P Shariah— MSCI Islamic0.2% MSCI Islamic M-Series— FTSE Shariah0.0% |
| HSTM HealthStream Inc | COMPLIANT | 0.01% | AAOIFI1.5% Usmani2.3% Dow Jones Islamic1.6% S&P Shariah1.6% MSCI Islamic2.3% MSCI Islamic M-Series1.6% FTSE Shariah0.0% |
| Sana Biotechnology Inc | UNSCREENED | 0.01% | no in-house ratios for this holding |
| STAA STAAR Surgical Co | COMPLIANT | 0.01% | AAOIFI2.6% Usmani6.9% Dow Jones Islamic3.0% S&P Shariah2.5% MSCI Islamic6.9% MSCI Islamic M-Series2.5% FTSE Shariah0.0% |
| MLAB Mesa Laboratories Inc | COMPLIANT | 0.01% | AAOIFI10.9% Usmani20.3% Dow Jones Islamic14.8% S&P Shariah14.6% MSCI Islamic20.3% MSCI Islamic M-Series14.6% FTSE Shariah15.9% |
| GLUE Monte Rosa Therapeutics Inc | NON_COMPLIANT | 0.01% | AAOIFI4.6% Usmani5.2% Dow Jones Islamic4.2% S&P Shariah5.4% MSCI Islamic5.2% MSCI Islamic M-Series5.4% FTSE Shariah0.0% |
| Aura Biosciences Inc | UNSCREENED | 0.01% | no in-house ratios for this holding |
| Theravance Biopharma Inc | UNSCREENED | 0.01% | no in-house ratios for this holding |
| MLTX MoonLake Immunotherapeutics | NON_COMPLIANT | 0.01% | AAOIFI10.6% Usmani18.8% Dow Jones Islamic4.7% S&P Shariah3.9% MSCI Islamic18.8% MSCI Islamic M-Series3.9% FTSE Shariah18.5% |
| ACRS Aclaris Therapeutics Inc | NON_COMPLIANT | 0.01% | AAOIFI0.3% Usmani0.8% Dow Jones Islamic0.4% S&P Shariah0.6% MSCI Islamic0.8% MSCI Islamic M-Series0.6% FTSE Shariah0.0% |
| WVE Wave Life Sciences Inc | NON_COMPLIANT | 0.01% | AAOIFI6.1% Usmani8.5% Dow Jones Islamic3.0% S&P Shariah3.5% MSCI Islamic8.5% MSCI Islamic M-Series3.5% FTSE Shariah0.0% |
| IRWD Ironwood Pharmaceuticals Inc | NON_COMPLIANT | 0.01% | AAOIFIfail Usmanifail Dow Jones Islamicfail S&P Shariahpass MSCI Islamicfail MSCI Islamic M-Seriespass FTSE Shariahfail |
| MAZE Maze Therapeutics Inc | COMPLIANT | 0.01% | AAOIFI3.3% Usmani11.7% Dow Jones Islamic4.7% S&P Shariahfail MSCI Islamic11.7% MSCI Islamic M-Seriesfail FTSE Shariah7.6% |
| ANNX Annexon Inc | COMPLIANT | 0.01% | AAOIFI9.8% Usmani29.2% Dow Jones Islamic46.7% S&P Shariah42.5% MSCI Islamic29.2% MSCI Islamic M-Series42.5% FTSE Shariah19.7% |
| Kestra Medical Technologies In | UNSCREENED | 0.01% | no in-house ratios for this holding |
| ALT Altimmune Inc | NON_COMPLIANT | 0.01% | AAOIFI11.3% Usmani7.3% Dow Jones Islamic7.7% S&P Shariah7.6% MSCI Islamic7.3% MSCI Islamic M-Series7.6% FTSE Shariah7.1% |
| ANGO AngioDynamics Inc | COMPLIANT | 0.01% | AAOIFIpass Usmanipass Dow Jones Islamicpass S&P Shariahpass MSCI Islamicpass MSCI Islamic M-Seriespass FTSE Shariahpass |
| CRMD CorMedix Inc | NON_COMPLIANT | 0.01% | AAOIFI0.0% Usmani0.0% Dow Jones Islamic0.0% S&P Shariah0.0% MSCI Islamic0.0% MSCI Islamic M-Series0.0% FTSE Shariah0.0% |
| BVS Bioventus Inc | COMPLIANT | 0.01% | AAOIFI26.3% Usmani36.3% Dow Jones Islamic30.0% S&P Shariah32.9% MSCI Islamic34.9% MSCI Islamic M-Series32.9% FTSE Shariah34.1% |
| Phreesia Inc | UNSCREENED | 0.01% | no in-house ratios for this holding |
| OPK OPKO Health Inc | NON_COMPLIANT | 0.01% | AAOIFI3.1% Usmani2.2% Dow Jones Islamic3.5% S&P Shariah3.7% MSCI Islamic2.0% MSCI Islamic M-Series3.7% FTSE Shariah0.1% |
| TYRA Tyra Biosciences Inc | COMPLIANT | 0.01% | AAOIFI0.4% Usmani0.8% Dow Jones Islamic0.5% S&P Shariah0.5% MSCI Islamic0.8% MSCI Islamic M-Series0.5% FTSE Shariah0.0% |
| ORIC ORIC Pharmaceuticals Inc | COMPLIANT | 0.01% | AAOIFI0.3% Usmani0.8% Dow Jones Islamic0.4% S&P Shariah0.4% MSCI Islamic0.8% MSCI Islamic M-Series0.4% FTSE Shariah0.0% |
| OLMA Olema Pharmaceuticals Inc | NON_COMPLIANT | 0.01% | AAOIFI0.1% Usmani0.1% Dow Jones Islamic0.0% S&P Shariah0.0% MSCI Islamic0.1% MSCI Islamic M-Series0.0% FTSE Shariah0.0% |
| CTMX CytomX Therapeutics Inc | NON_COMPLIANT | 0.01% | AAOIFI1.0% Usmani1.2% Dow Jones Islamic0.9% S&P Shariah1.2% MSCI Islamic1.2% MSCI Islamic M-Series1.2% FTSE Shariah0.0% |
| MDXG MiMedx Group Inc | COMPLIANT | 0.01% | AAOIFI0.0% Usmani0.0% Dow Jones Islamic0.0% S&P Shariah0.0% MSCI Islamic0.0% MSCI Islamic M-Series0.0% FTSE Shariah0.0% |
| TLRY Tilray Brands Inc | NON_COMPLIANT | 0.01% | AAOIFI52.0% Usmani12.8% Dow Jones Islamic20.7% S&P Shariah16.6% MSCI Islamic7.4% MSCI Islamic M-Series16.6% FTSE Shariah5.4% |
| CBLL Ceribell Inc | COMPLIANT | 0.01% | AAOIFI0.2% Usmani1.1% Dow Jones Islamic0.2% S&P Shariah— MSCI Islamic1.1% MSCI Islamic M-Series— FTSE Shariah0.0% |
| SLDB Solid Biosciences Inc | NON_COMPLIANT | 0.01% | AAOIFI2.8% Usmani5.0% Dow Jones Islamic3.8% S&P Shariah4.6% MSCI Islamic5.0% MSCI Islamic M-Series4.6% FTSE Shariah0.0% |
| CTKB Cytek Biosciences Inc | NON_COMPLIANT | 0.01% | AAOIFI2.2% Usmani3.6% Dow Jones Islamic2.7% S&P Shariah2.4% MSCI Islamic3.6% MSCI Islamic M-Series2.4% FTSE Shariah0.0% |
| ALLO Allogene Therapeutics Inc | NON_COMPLIANT | 0.01% | AAOIFI26.5% Usmani15.0% Dow Jones Islamic17.8% S&P Shariah16.2% MSCI Islamic15.0% MSCI Islamic M-Series16.2% FTSE Shariah0.0% |
| TCMD Tactile Systems Technology Inc | COMPLIANT | 0.01% | AAOIFI2.9% Usmani5.9% Dow Jones Islamic3.7% S&P Shariah4.1% MSCI Islamic5.9% MSCI Islamic M-Series4.1% FTSE Shariah0.0% |
| FDMT 4D Molecular Therapeutics Inc | NON_COMPLIANT | 0.01% | AAOIFI6.2% Usmani9.0% Dow Jones Islamic9.4% S&P Shariah6.5% MSCI Islamic9.0% MSCI Islamic M-Series6.5% FTSE Shariah4.6% |
| ARVN Arvinas Inc | NON_COMPLIANT | 0.01% | AAOIFI1.7% Usmani1.3% Dow Jones Islamic1.0% S&P Shariah0.6% MSCI Islamic1.3% MSCI Islamic M-Series0.6% FTSE Shariah0.1% |
| SVRA Savara Inc | NON_COMPLIANT | 0.01% | AAOIFI3.1% Usmani19.4% Dow Jones Islamic3.7% S&P Shariah4.0% MSCI Islamic19.4% MSCI Islamic M-Series4.0% FTSE Shariah19.4% |
| CERS Cerus Corp | COMPLIANT | 0.01% | AAOIFI3.1% Usmani5.7% Dow Jones Islamic3.1% S&P Shariah3.2% MSCI Islamic5.7% MSCI Islamic M-Series3.2% FTSE Shariah0.0% |
| LXRX Lexicon Pharmaceuticals Inc | NON_COMPLIANT | 0.01% | AAOIFI7.5% Usmani24.6% Dow Jones Islamic11.1% S&P Shariah11.4% MSCI Islamic24.6% MSCI Islamic M-Series11.4% FTSE Shariah21.4% |
| AHCO AdaptHealth Corp | NON_COMPLIANT | 0.01% | AAOIFI192.3% Usmani48.3% Dow Jones Islamic159.1% S&P Shariah158.0% MSCI Islamic47.9% MSCI Islamic M-Series158.0% FTSE Shariah44.8% |
| PHAT Phathom Pharmaceuticals Inc | NON_COMPLIANT | 0.01% | AAOIFI37.6% Usmani48.7% Dow Jones Islamic23.5% S&P Shariah24.1% MSCI Islamic48.7% MSCI Islamic M-Series24.1% FTSE Shariah48.0% |
| OMDA Omada Health Inc | COMPLIANT | 0.01% | AAOIFIpass Usmanifail Dow Jones Islamicpass S&P Shariahpass MSCI Islamicfail MSCI Islamic M-Seriespass FTSE Shariahfail |
| EDIT Editas Medicine Inc | NON_COMPLIANT | 0.01% | AAOIFI24.5% Usmani32.3% Dow Jones Islamic29.0% S&P Shariah21.2% MSCI Islamic32.3% MSCI Islamic M-Series21.2% FTSE Shariah25.9% |
| CAPR Capricor Therapeutics Inc | NON_COMPLIANT | 0.01% | AAOIFI19.1% Usmani27.9% Dow Jones Islamic11.8% S&P Shariah15.6% MSCI Islamic27.9% MSCI Islamic M-Series15.6% FTSE Shariah0.0% |
| VOR Vor BioPharma Inc | NON_COMPLIANT | 0.01% | AAOIFI0.2% Usmani0.6% Dow Jones Islamic0.7% S&P Shariah0.9% MSCI Islamic0.6% MSCI Islamic M-Series0.9% FTSE Shariah0.0% |
| OCGN Ocugen Inc | NON_COMPLIANT | 0.01% | AAOIFI2.1% Usmani5.0% Dow Jones Islamic1.5% S&P Shariah1.6% MSCI Islamic5.0% MSCI Islamic M-Series1.6% FTSE Shariah1.6% |
| EVH Evolent Health Inc | NON_COMPLIANT | 0.01% | AAOIFI178.1% Usmani49.6% Dow Jones Islamic124.3% S&P Shariah61.4% MSCI Islamic49.6% MSCI Islamic M-Series61.4% FTSE Shariah49.4% |
| RGNX REGENXBIO Inc | NON_COMPLIANT | 0.01% | AAOIFI13.9% Usmani14.3% Dow Jones Islamic13.6% S&P Shariah11.9% MSCI Islamic14.3% MSCI Islamic M-Series11.9% FTSE Shariah0.0% |
| EOLS Evolus Inc | NON_COMPLIANT | 0.01% | AAOIFI37.7% Usmani58.3% Dow Jones Islamic31.2% S&P Shariah26.9% MSCI Islamic58.3% MSCI Islamic M-Series26.9% FTSE Shariah55.3% |
| KIDS OrthoPediatrics Corp | COMPLIANT | 0.01% | AAOIFI12.3% Usmani19.9% Dow Jones Islamic19.3% S&P Shariah17.4% MSCI Islamic19.9% MSCI Islamic M-Series17.4% FTSE Shariah19.9% |
| PRTA Prothena Corp PLC | NON_COMPLIANT | 0.01% | AAOIFI1.5% Usmani2.2% Dow Jones Islamic1.2% S&P Shariah0.8% MSCI Islamic2.2% MSCI Islamic M-Series0.8% FTSE Shariah0.0% |
| STLN Starling Oncology Inc | COMPLIANT | 0.01% | AAOIFI15.0% Usmani58.6% Dow Jones Islamic34.3% S&P Shariah45.0% MSCI Islamic58.6% MSCI Islamic M-Series45.0% FTSE Shariah44.8% |
| VSTM Verastem Inc | NON_COMPLIANT | 0.01% | AAOIFIfail Usmanifail Dow Jones Islamicfail S&P Shariahfail MSCI Islamicfail MSCI Islamic M-Seriesfail FTSE Shariahfail |
| SEPN Septerna Inc | NON_COMPLIANT | 0.01% | AAOIFI1.2% Usmani3.6% Dow Jones Islamic2.1% S&P Shariahfail MSCI Islamic3.6% MSCI Islamic M-Seriesfail FTSE Shariah0.0% |
| NGNE Neurogene Inc | NON_COMPLIANT | 0.01% | AAOIFI1.6% Usmani2.0% Dow Jones Islamic2.0% S&P Shariah2.0% MSCI Islamic2.0% MSCI Islamic M-Series2.0% FTSE Shariah0.0% |
| PRME Prime Medicine Inc | NON_COMPLIANT | 0.01% | AAOIFI15.8% Usmani51.6% Dow Jones Islamic20.7% S&P Shariah19.0% MSCI Islamic51.6% MSCI Islamic M-Series19.0% FTSE Shariah0.0% |
| ARCT Arcturus Therapeutics Holdings Inc | NON_COMPLIANT | 0.01% | AAOIFIfail Usmanifail Dow Jones Islamicfail S&P Shariahpass MSCI Islamicfail MSCI Islamic M-Seriesfail FTSE Shariahfail |
| FLGT Fulgent Genetics Inc | NON_COMPLIANT | 0.01% | AAOIFI1.2% Usmani0.8% Dow Jones Islamic1.4% S&P Shariah1.3% MSCI Islamic0.8% MSCI Islamic M-Series1.3% FTSE Shariah0.0% |
| Shattuck Labs Inc | UNSCREENED | 0.00% | no in-house ratios for this holding |
| RLMD Relmada Therapeutics Inc | NON_COMPLIANT | 0.00% | AAOIFI0.0% Usmani0.0% Dow Jones Islamic0.0% S&P Shariah0.0% MSCI Islamic0.0% MSCI Islamic M-Series0.0% FTSE Shariah0.0% |
| OABI OmniAb Inc | NON_COMPLIANT | 0.00% | AAOIFI2.5% Usmani6.2% Dow Jones Islamic5.3% S&P Shariah4.4% MSCI Islamic6.2% MSCI Islamic M-Series4.4% FTSE Shariah0.0% |
| CBIO Crescent Biopharma Inc | NON_COMPLIANT | 0.00% | AAOIFI0.5% Usmani0.8% Dow Jones Islamic1.0% S&P Shariah1.3% MSCI Islamic0.8% MSCI Islamic M-Series1.3% FTSE Shariah0.0% |
| CYH Community Health Systems Inc | NON_COMPLIANT | 0.00% | AAOIFI3398.6% Usmani85.9% Dow Jones Islamic2343.1% S&P Shariah2175.3% MSCI Islamic84.3% MSCI Islamic M-Series2175.3% FTSE Shariah79.2% |
| PACB Pacific Biosciences of California Inc | NON_COMPLIANT | 0.00% | AAOIFI123.9% Usmani97.8% Dow Jones Islamic147.8% S&P Shariah107.9% MSCI Islamic97.8% MSCI Islamic M-Series107.9% FTSE Shariah89.2% |
| GDRX GoodRx Holdings Inc | NON_COMPLIANT | 0.00% | AAOIFI42.5% Usmani23.0% Dow Jones Islamic43.1% S&P Shariah33.1% MSCI Islamic23.0% MSCI Islamic M-Series33.1% FTSE Shariah20.8% |
| RCKT Rocket Pharmaceuticals Inc | NON_COMPLIANT | 0.00% | AAOIFI14.3% Usmani13.1% Dow Jones Islamic6.6% S&P Shariah3.2% MSCI Islamic8.1% MSCI Islamic M-Series3.2% FTSE Shariah7.3% |
| EYPT EyePoint Inc | NON_COMPLIANT | 0.00% | AAOIFIfail Usmanifail Dow Jones Islamicpass S&P Shariahpass MSCI Islamicfail MSCI Islamic M-Seriespass FTSE Shariahfail |
| STRO Sutro Biopharma Inc | NON_COMPLIANT | 0.00% | AAOIFIfail Usmanifail Dow Jones Islamicfail S&P Shariahfail MSCI Islamicfail MSCI Islamic M-Seriesfail FTSE Shariahfail |
| Simulations Plus Inc | UNSCREENED | 0.00% | no in-house ratios for this holding |
| EBS Emergent BioSolutions Inc | NON_COMPLIANT | 0.00% | AAOIFI172.0% Usmani51.6% Dow Jones Islamic118.8% S&P Shariah134.4% MSCI Islamic51.6% MSCI Islamic M-Series134.4% FTSE Shariah51.0% |
| OFIX Orthofix Medical Inc | NON_COMPLIANT | 0.00% | AAOIFI91.6% Usmani30.6% Dow Jones Islamic47.5% S&P Shariah47.0% MSCI Islamic29.1% MSCI Islamic M-Series47.0% FTSE Shariah25.9% |
| MYGN Myriad Genetics Inc | NON_COMPLIANT | 0.00% | AAOIFI39.4% Usmani34.4% Dow Jones Islamic32.8% S&P Shariah19.1% MSCI Islamic34.4% MSCI Islamic M-Series19.1% FTSE Shariah19.9% |
| Rezolute Inc | UNSCREENED | 0.00% | no in-house ratios for this holding |
| CATX Perspective Therapeutics Inc | NON_COMPLIANT | 0.00% | AAOIFI3.3% Usmani1.0% Dow Jones Islamic1.3% S&P Shariah0.9% MSCI Islamic1.0% MSCI Islamic M-Series0.9% FTSE Shariah0.4% |
| EMBC Embecta Corp | NON_COMPLIANT | 0.00% | AAOIFI467.7% Usmani118.7% Dow Jones Islamic228.0% S&P Shariah214.9% MSCI Islamic116.2% MSCI Islamic M-Series214.9% FTSE Shariah115.0% |
| RXST RxSight Inc | NON_COMPLIANT | 0.00% | AAOIFIfail Usmanifail Dow Jones Islamicfail S&P Shariahfail MSCI Islamicfail MSCI Islamic M-Seriesfail FTSE Shariahfail |
| SPRY ARS Pharmaceuticals Inc | NON_COMPLIANT | 0.00% | AAOIFI33.2% Usmani48.4% Dow Jones Islamic12.0% S&P Shariah12.4% MSCI Islamic48.4% MSCI Islamic M-Series12.4% FTSE Shariah48.4% |
| LMRI Lumexa Imaging Holdings Inc | NON_COMPLIANT | 0.00% | AAOIFI65.4% Usmani53.2% Dow Jones Islamic— S&P Shariah— MSCI Islamic50.2% MSCI Islamic M-Series— FTSE Shariah45.7% |
| ASMB Assembly Biosciences Inc | NON_COMPLIANT | 0.00% | AAOIFI0.5% Usmani0.7% Dow Jones Islamic0.7% S&P Shariah1.0% MSCI Islamic0.7% MSCI Islamic M-Series1.0% FTSE Shariah0.0% |
| VNDA Vanda Pharmaceuticals Inc | NON_COMPLIANT | 0.00% | AAOIFI6.8% Usmani5.7% Dow Jones Islamic4.9% S&P Shariah5.1% MSCI Islamic4.1% MSCI Islamic M-Series5.1% FTSE Shariah0.0% |
| ZNTL Zentalis Pharmaceuticals Inc | NON_COMPLIANT | 0.00% | AAOIFI19.8% Usmani13.6% Dow Jones Islamic20.7% S&P Shariah11.0% MSCI Islamic13.6% MSCI Islamic M-Series11.0% FTSE Shariah0.0% |
| AVIR Atea Pharmaceuticals Inc | NON_COMPLIANT | 0.00% | AAOIFI0.1% Usmani0.1% Dow Jones Islamic0.1% S&P Shariah0.1% MSCI Islamic0.1% MSCI Islamic M-Series0.1% FTSE Shariah0.0% |
| DNA Ginkgo Bioworks Holdings Inc | NON_COMPLIANT | 0.00% | AAOIFI72.1% Usmani42.1% Dow Jones Islamic65.3% S&P Shariah36.7% MSCI Islamic42.1% MSCI Islamic M-Series36.7% FTSE Shariah0.0% |
| TECX Tectonic Therapeutic Inc | NON_COMPLIANT | 0.00% | AAOIFI1.0% Usmani1.6% Dow Jones Islamic0.8% S&P Shariah1.0% MSCI Islamic1.6% MSCI Islamic M-Series1.0% FTSE Shariah0.0% |
| Anavex Life Sciences Corp | UNSCREENED | 0.00% | no in-house ratios for this holding |
| TMCI Treace Medical Concepts Inc | COMPLIANT | 0.00% | AAOIFI25.1% Usmani41.5% Dow Jones Islamic22.6% S&P Shariah18.5% MSCI Islamic41.5% MSCI Islamic M-Series18.5% FTSE Shariah33.5% |
| AKBA Akebia Therapeutics Inc | NON_COMPLIANT | 0.00% | AAOIFI45.9% Usmani17.7% Dow Jones Islamic12.5% S&P Shariah14.6% MSCI Islamic17.7% MSCI Islamic M-Series14.6% FTSE Shariah14.7% |
| FATE Fate Therapeutics Inc | NON_COMPLIANT | 0.00% | AAOIFI53.8% Usmani31.3% Dow Jones Islamic41.1% S&P Shariah27.4% MSCI Islamic31.3% MSCI Islamic M-Series27.4% FTSE Shariah0.0% |
| OSUR OraSure Technologies Inc | NON_COMPLIANT | 0.00% | AAOIFI4.7% Usmani3.3% Dow Jones Islamic4.8% S&P Shariah3.9% MSCI Islamic3.3% MSCI Islamic M-Series3.9% FTSE Shariah0.0% |
| LRMR Larimar Therapeutics Inc | NON_COMPLIANT | 0.00% | AAOIFI1.6% Usmani3.0% Dow Jones Islamic1.6% S&P Shariah1.4% MSCI Islamic3.0% MSCI Islamic M-Series1.4% FTSE Shariah0.0% |
| CMPX Compass Therapeutics Inc | NON_COMPLIANT | 0.00% | AAOIFI7.8% Usmani5.3% Dow Jones Islamic1.9% S&P Shariah2.3% MSCI Islamic5.3% MSCI Islamic M-Series2.3% FTSE Shariah0.0% |
| Multiplan Corp | UNSCREENED | 0.00% | no in-house ratios for this holding |
| FULC Fulcrum Therapeutics Inc | NON_COMPLIANT | 0.00% | AAOIFI2.4% Usmani2.2% Dow Jones Islamic1.9% S&P Shariah1.8% MSCI Islamic2.2% MSCI Islamic M-Series1.8% FTSE Shariah0.0% |
| KROS Keros Therapeutics Inc | NON_COMPLIANT | 0.00% | AAOIFI6.8% Usmani4.9% Dow Jones Islamic2.9% S&P Shariah1.6% MSCI Islamic4.9% MSCI Islamic M-Series1.6% FTSE Shariah0.0% |
| ALEC Alector Inc | NON_COMPLIANT | 0.00% | AAOIFI5.6% Usmani12.7% Dow Jones Islamic10.2% S&P Shariah6.7% MSCI Islamic12.7% MSCI Islamic M-Series6.7% FTSE Shariah0.0% |
| UPB Upstream Bio Inc | NON_COMPLIANT | 0.00% | AAOIFI0.4% Usmani0.3% Dow Jones Islamic0.1% S&P Shariah— MSCI Islamic0.3% MSCI Islamic M-Series— FTSE Shariah0.0% |
| LAB Standard BioTools Inc | NON_COMPLIANT | 0.00% | AAOIFIfail Usmanifail Dow Jones Islamicfail S&P Shariahfail MSCI Islamicfail MSCI Islamic M-Seriesfail FTSE Shariahfail |
| SIGA SIGA Technologies Inc | NON_COMPLIANT | 0.00% | AAOIFI0.1% Usmani0.2% Dow Jones Islamic0.1% S&P Shariah0.1% MSCI Islamic0.2% MSCI Islamic M-Series0.1% FTSE Shariah0.0% |
| EVMN Evommune Inc | NON_COMPLIANT | 0.00% | AAOIFI2.5% Usmani2.9% Dow Jones Islamicfail S&P Shariahfail MSCI Islamic2.7% MSCI Islamic M-Seriesfail FTSE Shariah0.0% |
| TRDA Entrada Therapeutics Inc | NON_COMPLIANT | 0.00% | AAOIFI23.1% Usmani17.7% Dow Jones Islamic13.4% S&P Shariah11.5% MSCI Islamic17.7% MSCI Islamic M-Series11.5% FTSE Shariah0.0% |
| LYEL Lyell Immunopharma Inc | NON_COMPLIANT | 0.00% | AAOIFI13.2% Usmani16.2% Dow Jones Islamic14.3% S&P Shariah12.1% MSCI Islamic16.2% MSCI Islamic M-Series12.1% FTSE Shariah0.0% |
| MPLT MapLight Therapeutics Inc | NON_COMPLIANT | 0.00% | AAOIFI0.3% Usmani0.5% Dow Jones Islamic— S&P Shariah— MSCI Islamic0.5% MSCI Islamic M-Series— FTSE Shariah0.0% |
| IPSC Century Therapeutics Inc | NON_COMPLIANT | 0.00% | AAOIFI12.6% Usmani14.3% Dow Jones Islamic20.7% S&P Shariah20.1% MSCI Islamic14.3% MSCI Islamic M-Series20.1% FTSE Shariah0.0% |
| QSI Quantum-Si Inc | NON_COMPLIANT | 0.00% | AAOIFI1.3% Usmani1.6% Dow Jones Islamic— S&P Shariah— MSCI Islamic1.6% MSCI Islamic M-Series— FTSE Shariah0.0% |
| MXCT MaxCyte Inc | NON_COMPLIANT | 0.00% | AAOIFI14.0% Usmani9.3% Dow Jones Islamic8.3% S&P Shariah5.9% MSCI Islamic9.3% MSCI Islamic M-Series5.9% FTSE Shariah0.0% |
| KRRO Korro Bio Inc | NON_COMPLIANT | 0.00% | AAOIFI24.6% Usmani28.0% Dow Jones Islamic20.3% S&P Shariah17.4% MSCI Islamic28.0% MSCI Islamic M-Series17.4% FTSE Shariah0.0% |
| N/A | UNSCREENED | 0.00% | no in-house ratios for this holding |
| HUMA Humacyte Inc | NON_COMPLIANT | 0.00% | AAOIFI24.5% Usmani52.9% Dow Jones Islamic13.2% S&P Shariah9.9% MSCI Islamic29.3% MSCI Islamic M-Series9.9% FTSE Shariah29.3% |
| ORGO Organogenesis Holdings Inc | COMPLIANT | 0.00% | AAOIFIfail Usmanipass Dow Jones Islamicpass S&P Shariahpass MSCI Islamicpass MSCI Islamic M-Seriespass FTSE Shariahpass |
| QTRX Quanterix Corp | NON_COMPLIANT | 0.00% | AAOIFI23.1% Usmani10.4% Dow Jones Islamic13.0% S&P Shariah8.0% MSCI Islamic10.4% MSCI Islamic M-Series8.0% FTSE Shariah0.0% |
| LENZ LENZ Therapeutics Inc | NON_COMPLIANT | 0.00% | AAOIFI0.4% Usmani0.2% Dow Jones Islamic0.1% S&P Shariah0.1% MSCI Islamic0.2% MSCI Islamic M-Series0.1% FTSE Shariah0.0% |
| Neumora Therapeutics Inc | UNSCREENED | 0.00% | no in-house ratios for this holding |
| SION Sionna Therapeutics Inc | NON_COMPLIANT | 0.00% | AAOIFI5.6% Usmani2.9% Dow Jones Islamic0.7% S&P Shariah— MSCI Islamic2.9% MSCI Islamic M-Series— FTSE Shariah0.0% |
| ALDX Aldeyra Therapeutics Inc | NON_COMPLIANT | 0.00% | AAOIFI1.2% Usmani1.1% Dow Jones Islamic0.2% S&P Shariah0.2% MSCI Islamic1.1% MSCI Islamic M-Series0.2% FTSE Shariah0.0% |
| Accendra Health Inc | UNSCREENED | 0.00% | no in-house ratios for this holding |
| HCAT Health Catalyst Inc | NON_COMPLIANT | 0.00% | AAOIFI15.0% Usmani6.6% Dow Jones Islamic7.3% S&P Shariah5.2% MSCI Islamic6.6% MSCI Islamic M-Series5.2% FTSE Shariah0.0% |
| PLRX Pliant Therapeutics Inc | NON_COMPLIANT | 0.00% | AAOIFI67.9% Usmani16.4% Dow Jones Islamic17.0% S&P Shariah7.1% MSCI Islamic16.4% MSCI Islamic M-Series7.1% FTSE Shariah0.0% |
| HRTX Heron Therapeutics Inc | NON_COMPLIANT | 0.00% | AAOIFI74.1% Usmani17.4% Dow Jones Islamic19.7% S&P Shariah15.7% MSCI Islamic17.4% MSCI Islamic M-Series15.7% FTSE Shariah14.9% |
| FLNA Filana Therapeutics Inc | NON_COMPLIANT | 0.00% | AAOIFI0.0% Usmani0.0% Dow Jones Islamic0.0% S&P Shariah0.0% MSCI Islamic0.0% MSCI Islamic M-Series0.0% FTSE Shariah0.0% |
| DCGO DocGo Inc | NON_COMPLIANT | 0.00% | AAOIFI49.5% Usmani14.2% Dow Jones Islamic5.9% S&P Shariah4.0% MSCI Islamic5.4% MSCI Islamic M-Series4.0% FTSE Shariah0.1% |
| GOSS Gossamer Bio Inc | NON_COMPLIANT | 0.00% | AAOIFIfail Usmanifail Dow Jones Islamic— S&P Shariah— MSCI Islamicfail MSCI Islamic M-Series— FTSE Shariahfail |
| N/A | UNSCREENED | 0.00% | no in-house ratios for this holding |
| DH Definitive Healthcare Corp | NON_COMPLIANT | 0.00% | AAOIFI89.8% Usmani33.6% Dow Jones Islamic59.9% S&P Shariah37.3% MSCI Islamic33.6% MSCI Islamic M-Series37.3% FTSE Shariah32.4% |
| N/A | UNSCREENED | 0.00% | no in-house ratios for this holding |
| Hologic Inc | UNSCREENED | 0.00% | no in-house ratios for this holding |
| RO.SW Roche Holding AG | COMPLIANT | 0.00% | AAOIFIpass Usmanifail Dow Jones Islamicpass S&P Shariahpass MSCI Islamicpass MSCI Islamic M-Seriespass FTSE Shariahpass |
| Prevail Therapeutics Inc | UNSCREENED | 0.00% | no in-house ratios for this holding |
| OABI OmniAb Inc | NON_COMPLIANT | 0.00% | AAOIFI2.5% Usmani6.2% Dow Jones Islamic5.3% S&P Shariah4.4% MSCI Islamic6.2% MSCI Islamic M-Series4.4% FTSE Shariah0.0% |
| OABI OmniAb Inc | NON_COMPLIANT | 0.00% | AAOIFI2.5% Usmani6.2% Dow Jones Islamic5.3% S&P Shariah4.4% MSCI Islamic6.2% MSCI Islamic M-Series4.4% FTSE Shariah0.0% |
| Chinook Therapeutics Inc | UNSCREENED | 0.00% | no in-house ratios for this holding |
The published standards disagree about this fund by 39 points of portfolio weight — 79.0% of it passes AAOIFI, 39.9% passes MSCI Islamic. Which number is yours depends on which standard you follow.
These bars are the financial-ratio result under each standard — debt, receivables and interest income. They do not screen what the business does, so a holding can pass every ratio here and still be questionable or non-compliant on activity. The blended verdict above accounts for both.
ratios pass on 79.0% ratios fail on 17.9% 3.1% not rated under AAOIFI
ratios pass on 46.5% ratios fail on 50.2% 3.4% not rated under Usmani
ratios pass on 77.7% ratios fail on 18.7% 3.7% not rated under Dow Jones Islamic
ratios pass on 78.4% ratios fail on 17.7% 3.9% not rated under S&P Shariah
ratios pass on 39.9% ratios fail on 56.9% 3.2% not rated under MSCI Islamic
ratios pass on 77.5% ratios fail on 18.8% 3.8% not rated under MSCI Islamic M-Series
ratios pass on 48.2% ratios fail on 48.6% 3.2% not rated under FTSE Shariah
347 of 423 listed holdings carry our own per-methodology verdicts (97% of weight). The rest hold a provider verdict with no methodology breakdown, and are counted as rated by none. Of those, 325 (97% of weight) also carry the underlying debt ratio; the rest show a verdict without the figure behind it.
| Non-compliant holding | Weight |
|---|---|
| UNH UnitedHealth Group Inc | 4.90% |
| PFE Pfizer Inc | 2.24% |
| BMY Bristol-Myers Squibb Co | 1.89% |
| CVS CVS Health Corp | 1.65% |
| ELV Elevance Health Inc | 1.16% |
| CI Cigna Group/The | 1.01% |
| HCA HCA Healthcare Inc | 0.90% |
| BDX Becton Dickinson & Co | 0.74% |
| HUM Humana Inc | 0.64% |
| IQV IQVIA Holdings Inc | 0.61% |
Methodology breakdown computing — it will appear here on its own.
Trade setup
Whether the technical picture shows an edge right now. Separate from the Sharia verdict, which this side never overrides.
Why this signal?
The factors behind the read, each shown with the figure it rests on, including the ones pointing the other way.
VANGUARD HEALTH CARE INDEX FUND (VHT) is currently considered not halal (non-compliant), per our own look-through to its filed holdings. See its filed holdings and the weight breakdown below for the reasoning.
Still fetching analyst coverage — it ran past this page's budget, so the page painted without waiting. The fetch is still running; reload in a moment and it will be here.
🕌 In-house Compliance Research
Computing the full ratio and business-activity breakdown for VHT — this runs off the critical path so the page paints first. It will appear here on its own.
| Investor | Firm | Position | Weight | As of |
|---|---|---|---|---|
| Ken Griffin | Citadel Advisors | $21M | 0.0% | 2026-09-30 |
| Joel Greenblatt | Gotham Asset Management | $3M | 0.0% | 2026-09-30 |
| Ken Fisher | Fisher Asset Management | $1M | 0.0% | 2026-09-30 |
| Paul Tudor Jones | Tudor Investment Corp | $0M | 0.0% | 2026-09-30 |
From the most recent 13F on file. A 13F reports long US equity positions quarterly and in arrears — it is what a manager held on the report date, not what they hold today.
Pinch or scroll to zoom · drag to pan — both axes move · double-click to reset
Classic floor-trader pivots from the last completed daily bar. Highlighted pills are the levels bracketing the current price.
Price Forecast
The range is measured volatility (ATR over the horizon), not a target — a wider band means a more volatile asset, not a stronger view. The direction is the indicator tally below. Every forecast is recorded when made and scored against the real price when it comes due, including the wrong ones. Not a recommendation, and not a fatwa.
Technical Summary
Standard indicator thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20, MACD histogram sign, price vs. average) computed on daily bars. A summary of what common indicators say — not a recommendation, and not this site's own trading verdict.
Every indicator, and what it reads
| Indicator | Value | Signal |
|---|---|---|
| RSI (14) | 46.20 | NEUTRAL |
| Stochastic %K (14) | 3.53 | BUY |
| CCI (20) | -72.82 | NEUTRAL |
| Williams %R (14) | -96.47 | BUY |
| MACD (12,26,9) | -1.49 | SELL |
| ROC (10) | -4.81 | SELL |
| Momentum (10) | -16.89 | SELL |
| EMA (10) | 342.58 | SELL |
| SMA (10) | 344.41 | SELL |
| EMA (20) | 340.03 | SELL |
| SMA (20) | 341.54 | SELL |
| EMA (30) | 336.67 | SELL |
| SMA (30) | 335.73 | SELL |
| EMA (50) | 330.88 | BUY |
| SMA (50) | 327.55 | BUY |
| EMA (100) | 319.92 | BUY |
| SMA (100) | 319.33 | BUY |
| EMA (200) | 304.35 | BUY |
| SMA (200) | 298.47 | BUY |
About VANGUARD HEALTH CARE INDEX FUND
The fund employs an indexing investment approach designed to track the performance of the index, an index made up of stocks of large, mid-size, and small U.S. companies within the health care sector, as classified under the GICS. The Advisor attempts to replicate the target index by seeking to invest all, or substantially all, of its assets in the stocks that make up the index, in order to hold each stock in approximately the same proportion as its weighting in the index. The fund is non-diversified.
Background via Yahoo Finance — informational, not part of the verdict.
Average — needs more confirmation before sizing up
SMC — Top Down
Market structure by timeframe, read from real bars. A bias per timeframe rather than a forecast — timeframes disagreeing is information, not noise.
| Timeframe | Bias | Bars |
|---|---|---|
| 📅 Daily | BEARISH | 43 |
| ⏰ 4H | BEARISH | 39 |
| 🕐 1H | BEARISH | 98 |
| ⏱ 15-Min | BEARISH | 130 |
| ⏲ 5-Min | BEARISH | 234 |
Momentum & Volume
Rate of change and relative volume against this symbol's own recent history. Momentum describes what price has done; it is not a claim about what it will do.
Peer Movement
How the rest of the sector moved over the same window. Context for a price move, never a cause of one.
Peer movement computing — it will appear here on its own.
Before you act on this
The questions worth asking about any verdict on this page, answered plainly.
Is a fund screened on its name?
No. HTR reads the fund's filed holdings and screens each one, then reports the result by weight. A fund marketed as Islamic still gets the same look-through as any other.
What does unrated weight mean?
It is the share of the fund whose holdings HTR cannot cover far enough to rate. It is reported as unrated rather than counted as compliant, because a holding nobody screened should not look like one that passed.
Does the issuer's board make it compliant?
It matters, and it is noted, but it does not replace the look-through. The board's judgement and the holdings screen are shown separately so you can see when they agree and when they do not.
How often is this re-screened?
When the fund files new holdings, and on a rolling basis besides. The date on the verdict above is the last time this fund was actually recomputed.
Open research, not a fatwa. HTR applies published screening standards to filings and publishes what they say, including when they disagree. Nothing here is financial advice or a recommendation to buy or sell. Verdicts can change when new filings land.
Compare with
Same screen, different answers. Comparison is where the standards disagreeing becomes useful rather than confusing.
Peer screening computing — it will appear here on its own.
Still fetching insider filings — it ran past this page's budget, so the page painted without waiting. The fetch is still running; reload in a moment and it will be here.
COT Positioning — E-MINI S&P 500 - CHICAGO MERCANTILE EXCHANGE
The weekly CFTC Commitments of Traders report for the broad market it tracks, not for this symbol. Positioning context for the tape — it says nothing about this company.
NEUTRAL report date 2026-11-10 · Asset managers net 914130 (-14454)
AI Summary
Plain-language summary of the evidence already on this page — the Sharia screen, structure, momentum, and order flow above. It explains the read; it doesn't make the call. Generated on demand (a live AI call), never run automatically.